Ireland - HealthQuill

Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according to a company statement.

Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval

Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.

by HealthQuill
February 24, 2025
0 Comments

China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight cancer for an upfront payment of $925 million.

Drugs Medical Pharma

WuXi Biologics sells global rights to cancer antibody to Candid for $925m

China’s WuXi Biologics, a clinical research organization, has granted global rights to US-based Candid Therapeutics to use the company’s synthetic antibody to fight.

by HealthQuill
January 7, 2025
0 Comments

Israel has passed a law to ban the United Nations Relief and Works Agency from operating in the country after it earlier accused its employees of participation in the October 7 attacks — a move which came in for criticism from Western European leaders.

Drugs Health Medical

Israel bans UN relief agency, EU, Western European leaders slam move

Israel has passed a law to ban the UN relief agency, UNRWA, from operating in the country after it earlier accused its employees.

by HealthQuill
October 29, 2024
0 Comments

Eli Lilly and Company will invest one billion dollars to expand its facility in Ireland to increase its production of drugs to treat Alzheimer’s disease, diabetes and obesity, according to a company statement.

Drugs Health Pharma

Eli Lilly to invest $1b in Irish facility to make Alzheimer’s, obesity drugs

Eli Lilly and Company will invest one billion dollars to expand its facility in Ireland to increase its production of drugs to treat.

by HealthQuill
September 12, 2024
0 Comments

Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two drugs that treat rare inflammatory diseases.

Drugs Health Pharma

Amgen completes $27.8b acquisition of Horizon Therapeutics

Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two.